OTC Pharmaceuticals - Morocco

  • Morocco
  • Revenue in the OTC Pharmaceuticals market amounts to €459.90m in 2024. The market is expected to grow annually by 4.53% (CAGR 2024-2029).
  • The market's largest segment is the segment Analgesics with a market volume of €108.10m in 2024.
  • In global comparison, most revenue is generated in the United States (€37,850m in 2024).
  • In relation to total population figures, per person revenues of €12.03 are generated in 2024.
  • In the OTC Pharmaceuticals market, 5.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The OTC Pharmaceuticals market in Morocco has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.

Customer preferences play a crucial role in the growth of the OTC Pharmaceuticals market in Morocco. Consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. Over-the-counter medications provide a convenient and affordable option for individuals to address common health issues without the need for a prescription.

This preference for self-medication has fueled the demand for OTC Pharmaceuticals in Morocco. Trends in the market have also contributed to the growth of the OTC Pharmaceuticals sector in Morocco. One notable trend is the increasing prevalence of lifestyle-related health issues.

With changing lifestyles and dietary habits, conditions such as obesity, diabetes, and cardiovascular diseases have become more common. As a result, there is a growing demand for OTC medications that can help manage these conditions. Additionally, the aging population in Morocco has led to an increased need for OTC medications that address age-related health concerns.

Local special circumstances have further influenced the development of the OTC Pharmaceuticals market in Morocco. The country has a well-established healthcare system, with a network of pharmacies and healthcare professionals. This infrastructure provides easy access to OTC medications for consumers.

Furthermore, the Moroccan government has implemented policies to promote the use of generic medications, which are often available over the counter. This has made OTC Pharmaceuticals more affordable and accessible to a wider population. Underlying macroeconomic factors have also played a role in the growth of the OTC Pharmaceuticals market in Morocco.

The country has experienced steady economic growth in recent years, leading to an increase in disposable income. As a result, consumers have more purchasing power to spend on healthcare products, including OTC medications. Additionally, the government has implemented healthcare reforms to improve access to healthcare services, which has further contributed to the growth of the OTC Pharmaceuticals market.

In conclusion, the OTC Pharmaceuticals market in Morocco is experiencing significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility of OTC medications, along with the increasing prevalence of lifestyle-related health issues, have driven the demand for OTC Pharmaceuticals. The well-established healthcare system, government policies, and economic growth have further supported the growth of this market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)